病毒
抗病毒药物
冠状病毒
病毒生命周期
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
2019年冠状病毒病(COVID-19)
病毒学
药物发现
药品
药物开发
传染病(医学专业)
生物
疾病
医学
生物信息学
药理学
病毒复制
病理
作者
Soodabeh Rostami,Shima Gharibi,Hajar Yaghoobi,Zary Nokhodian,Parisa Shoaei,Armina Alaghband Bahrami,Shahrzad Ahangarzadeh,Abbas Alibakhshi
标识
DOI:10.2174/1381612828666220802121014
摘要
Coronavirus disease 2019 (COVID-19) is the result of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Understanding molecular pathogenesis is an essential factor for the allocation of effective preventive measures and the development of targeted therapeutics against COVID-19. The genome of SARS-CoV-2 encodes structural and nonstructural proteins, which can be targets for compounds with potential therapeutic ability. On the other hand, the virus life cycle has stages susceptible to targeting by drug compounds. Many natural antiviral compounds have been studied and evaluated at the cellular and molecular levels with antiviral potential. Meanwhile, many studies over the past few months have shown that plant polysaccharides have a good ability to target proteins and stages of the virus life cycle. In this regard, in this review study, the virus specifications and infectious process and structural and functional components of SARSCoV- 2 will be reviewed, and then the latest studies on the effect of plant compounds with more focus on polysaccharides on viral targets and their inhibitory potential on the infectious process of COVID-19 will be discussed.
科研通智能强力驱动
Strongly Powered by AbleSci AI